Bookmark and Share

BioActivity Data for Compound Methenamine (CID 4101)

BioActivity Outcomes:
Active(3)
 
 
Inactive(799)
 
 
Inconclusive(40)
 
 
Unspecified(31)
 
 
Top Targets:
7tm 4(28)
 
 
NR LBD PPAR(24)
 
 
 
NR LBD AR(21)
 
 
NR LBD ER(21)
 
 
NR LBD VDR(14)
 
 
 
BioAssay Types:
Confirmatory(391)
 
 
 
 
Screening(308)
 
 
Summary(87)
 
 
 
Literature(29)
 
 
 
BioAssay Categories:
In vitro(3)
 
 
 
In vivo(5)
 
 
 
Biochemical(106)
 
 
Toxicity(34)
 
 
 
 
ADME(16)
 
 
Cell-based(98)
 
 
 
 
Organism-base..(10)
 
 
 
BioActivity Types:
Potency(432)
 
 
 
 
AC50(12)
 
 
 
IC50(11)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 607    Data Row: 873   Total Pages: 44   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID48415038]
DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity [AID1188, Type: other]
View
2
[SID48413850]
DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity [AID1194, Type: other]
View
3
[SID57260105]
Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other]
View
4
[SID8149416]
Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other]
View
5
[SID8149416]
Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other]
View
6
[SID8149416]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other]
View
7
[SID8149416]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other]
View
8
[SID8149416]
Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other]
View
9
[SID123097024]
Oil-water partition coefficient, log P of the compound [AID1134605, Type: Literature]
View
10
[SID123097024]
Et2O-water partition coefficient, log P of the compound [AID1134606, Type: Literature]
View
11
[SID8149416]
Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other]
View
12
[SID8149416]
Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other]
View
13
[SID8149416]
Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other]
View
14
[SID57260105]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
15
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis [AID625281, Type: Literature]
View
16
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice [AID625288, Type: Literature]
View
17
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease [AID625289, Type: Literature]
View
18
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty [AID625290, Type: Literature]
View
19
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal [AID625291, Type: Literature]
View
20
[SID123097024]
Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score [AID625292, Type: Literature]
View